N-Farnesyloxy-norcantharimide and N-farnesyl-norcantharimide inhibit the progression of leukemia and increase survival days in a syngeneic mouse leukemia model-Reference-Cited by-同舟云学术

N-Farnesyloxy-norcantharimide and N-farnesyl-norcantharimide inhibit the progression of leukemia and increase survival days in a syngeneic mouse leukemia model

Published:2015-06 Issue:5 Volume:26 Page:508-517
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Chang Ming-Che,Tsai En-Tung,Wu Jin-Yi,Liao Hui-Fen,Chen Yu-Jen,Kuo Cheng-Deng

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference28 articles.

1. Medical uses of mylabris in ancient China and recent studies.;Wang;J Ethnopharmacol,1989

2. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.;Chen;Int J Cancer,2002

3. Inhibitory effect of norcantharidin, a derivative compound from blister beetles, on tumor invasion and metastasis in CT26 colorectal adenocarcinoma cells.;Chen;Anticancer Drugs,2005

4. A small-molecule metastasis inhibitor, norcantharidin, downregulates matrix metalloproteinase-9 expression by inhibiting Sp1 transcriptional activity in colorectal cancer cells.;Chen;Chem Biol Interact,2009

5. Cantharidin, another natural toxin that inhibits the activity of serinethreonine protein phosphatases types 1 and 2A.;Honkanen;FEBS Lett,1993

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin;Molecules;2022-11-10

2. Inhibition of Jurkat T Cell Growth by N-farnesyl-norcantharimide Through Up-regulation of Tumor Suppressor Genes and Down-regulation of Genes for Steroid Biosynthesis, Metabolic Pathways and Fatty Acid Metabolism;Anticancer Research;2020-05

3. Long‐noncoding RNA HOTAIR inhibits immunologic rejection of mouse leukemia cells through activating the Wnt/β‐catenin signaling pathway in a mouse model of leukemia;Journal of Cellular Physiology;2019-01-04

4. Comparative assessment of therapeutic safety of norcantharidin, N-farnesyloxy-norcantharimide, and N-farnesyl-norcantharimide against Jurkat T cells relative to human normal lymphoblast;Medicine;2016-08

5. Synthesis, crystal structure, spectroscopic properties and potential anti-cancerous activities of four unsaturated bis-norcantharimides;Journal of Molecular Structure;2016-07